Literature DB >> 14066415

ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE.

H F HASENCLEVER, W O MITCHELL.   

Abstract

Hasenclever, H. F. (National Institute of Allergy and Infectious Diseases, Bethesda, Md.) and William O. Mitchell. Acquired immunity to candidiasis in mice. J. Bacteriol. 86:401-406. 1963.-Some protection to chronic candidiasis in mice was produced by sublethal intraperitoneal infection with Candida albicans and by the injection in incomplete Freund's adjuvant of nonviable Coccidioides immitis spherule fragments. Other pathogenic or nonpathogenic fungi produced little or no protection. Salmonella enteritidis lipopolysaccharide, known to protect mice against the acute toxic manifestations of C. albicans, had no effect upon chronic candidiasis. A factor active in vitro against the growth of C. albicans was shown to be in the serum of resistant mice.

Entities:  

Keywords:  ENDOTOXINS; EXPERIMENTAL LAB STUDY; FREUND'S ADJUVANT; IMMUNE SERUMS; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; MONILIASIS; PHARMACOLOGY; SALMONELLA

Mesh:

Substances:

Year:  1963        PMID: 14066415      PMCID: PMC278449          DOI: 10.1128/jb.86.3.401-406.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  10 in total

1.  Symposium on bacterial endotoxins. II. Possible mechanisms whereby endotoxins evoke increased nonspecific resistance to infection.

Authors:  J L WHITBY; J G MICHAEL; M W WOODS; M LANDY
Journal:  Bacteriol Rev       Date:  1961-12

2.  Endotoxin susceptibility and delayed hypersensitivity in experimental histoplasmosis.

Authors:  E D BOX; N T BRIGGS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

3.  Active immunization of mice against Candida albicans.

Authors:  S MOURAD; L FRIEDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1961-03

4.  Immunity in experimental moniliasis.

Authors:  H I WINNER
Journal:  J Pathol Bacteriol       Date:  1956-01

5.  Candida albicans infections in actively and passively immunized animals.

Authors:  R C HURD; C H DRAKE
Journal:  Mycopathol Mycol Appl       Date:  1953-10-31

6.  Production in mice of tolerance to the toxic manifestations of Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

7.  Production of tolerance to the toxicity of Candida albicans by nonfungal materials.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

8.  ENDOTOXIN-INDUCED TOLERANCE TO TOXIC MANIFESTATIONS OF CANDIDA ALBICANS.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

9.  Specific and non-specific immunity in experimental cryptococcosis in mice.

Authors:  D B LOURIA
Journal:  J Exp Med       Date:  1960-05-01       Impact factor: 14.307

10.  Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

  10 in total
  13 in total

Review 1.  The in vitro interactions of Candida albicans with nonspecific serum proteins.

Authors:  H F Hasenclever
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

Review 2.  Experimentally induced immunity in the mycoses.

Authors:  Y C Kong; H B Levine
Journal:  Bacteriol Rev       Date:  1967-03

Review 3.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

4.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis.

Authors:  W M Scheld; R A Calderone; J P Brodeur; M A Sande
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Pathological observations in experimental candida infection of sensitized guinea pigs.

Authors:  M Isoda
Journal:  Mycopathologia       Date:  1985-09       Impact factor: 2.574

7.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Immunity to experimental renal candidiasis in rats.

Authors:  T J Rogers; E Balish
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Experimental Candida albicans infection in conventional mice and germfree rats.

Authors:  T Rogers; E Balish
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice.

Authors:  P K Maiti; A Kumar; R Kumar; L N Mohapatra
Journal:  Mycopathologia       Date:  1985-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.